A Prospective Study On The Impact of Hba1c (Glycosylated Haemoglobin) On Diabetic Foot Morbidity And Its Correlation With Clinical Variables.

This prospective study investigates the potential impact of glycated hemoglobin (HbA1c) levels on diabetic foot morbidity and explores its potential correlation with a range of clinical factors. Diabetic foot complications present a significant healthcare challenge, and HbA1c serves as a well-established marker for long-term glycemic control. Gaining insights into the potential relationship between HbA1c levels and foot morbidity holds the promise of enhancing patient care and management. The study employs [describe the study design, sample size, and Inclusion criteria], with a focus on categorizing participants’ HbA1c levels. Concurrently, clinical variables including neuropathy, vascular status, and foot deformities are evaluated.